De Groot CJ - Search Results

1

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.

Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D. Lindberg RL, et al. Among authors: de groot cj. Brain. 2001 Sep;124(Pt 9):1743-53. doi: 10.1093/brain/124.9.1743. Brain. 2001. PMID: 11522577

2

Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.

Lindberg RL, De Groot CJ, Certa U, Ravid R, Hoffmann F, Kappos L, Leppert D. Lindberg RL, et al. Among authors: de groot cj. J Neuroimmunol. 2004 Jul;152(1-2):154-67. doi: 10.1016/j.jneuroim.2004.03.011. J Neuroimmunol. 2004. PMID: 15223248

3

Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.

Hulshof S, Montagne L, De Groot CJ, Van Der Valk P. Hulshof S, et al. Among authors: de groot cj. Glia. 2002 Apr 1;38(1):24-35. doi: 10.1002/glia.10050. Glia. 2002. PMID: 11921201

4

Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.

De Groot CJ, Montagne L, Barten AD, Sminia P, Van Der Valk P. De Groot CJ, et al. J Neuropathol Exp Neurol. 1999 Feb;58(2):174-87. doi: 10.1097/00005072-199902000-00007. J Neuropathol Exp Neurol. 1999. PMID: 10029100

5

Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions.

De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, van der Valk P. De Groot CJ, et al. Brain. 2001 Aug;124(Pt 8):1635-45. doi: 10.1093/brain/124.8.1635. Brain. 2001. PMID: 11459754

6

Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions.

Gobin SJ, Montagne L, Van Zutphen M, Van Der Valk P, Van Den Elsen PJ, De Groot CJ. Gobin SJ, et al. Among authors: de groot cj. Glia. 2001 Oct;36(1):68-77. doi: 10.1002/glia.1096. Glia. 2001. PMID: 11571785

7

Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.

De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P. De Groot CJ, et al. J Neuropathol Exp Neurol. 1997 Jan;56(1):10-20. doi: 10.1097/00005072-199701000-00002. J Neuropathol Exp Neurol. 1997. PMID: 8990125

8

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

van der Valk P, De Groot CJ. van der Valk P, et al. Among authors: de groot cj. Neuropathol Appl Neurobiol. 2000 Feb;26(1):2-10. doi: 10.1046/j.1365-2990.2000.00217.x. Neuropathol Appl Neurobiol. 2000. PMID: 10736062 Review.

9

Hypothalamic lesions in multiple sclerosis.

Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF. Huitinga I, et al. Among authors: de groot cj. J Neuropathol Exp Neurol. 2001 Dec;60(12):1208-18. doi: 10.1093/jnen/60.12.1208. J Neuropathol Exp Neurol. 2001. PMID: 11764093

10

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.

Cossins JA, Clements JM, Ford J, Miller KM, Pigott R, Vos W, Van der Valk P, De Groot CJ. Cossins JA, et al. Among authors: de groot cj. Acta Neuropathol. 1997 Dec;94(6):590-8. doi: 10.1007/s004010050754. Acta Neuropathol. 1997. PMID: 9444361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters